A phase II study of Conbination therapy of Carboplatin/Paclitaxel/Bavacizumab in previously untreated patients with StageIIIB/IV non-small cell lung cancer - A phase II study of Conbination therapy of Carboplatin/Paclitaxel/Bavacizumab in previously untreated patients with StageIIIB/IV non-small cell lung cancer

Yamagata University School of Medicine0 个研究点目标入组 44 人开始时间: 2011年7月30日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients with untreated Brain metastases 2)Patients with current or previous history of hemoptysis (2.5mL or more) 3)Patients with uncontrolled hyper tension 4)Patients with uncontrolled infection 5)Patients with active lung disease such as interstitial pneumonia, pneumoconiosis, active radiation pneumonitis, pulmonary fibrosis or drug-induced pneumonitis 6)Patients with uncontrollable complications 7)Patients with massive pleural or pericardial effusion,or ascites 8)Patients with active concomitant malignancy 9)Patients with previous histories of drug allergy 10)Patients with uncontrollable gastrointestinal ulceration 11)Patients with current or previous (within one year) history of gastrointestinal perforation 12)Patients with therapeutic anticoagulopathy (including Aspirin over 325mg/day) 13)Pregnancy or lactation 14)Inappropriate patients for this study judged by the physicians

发起方

Yamagata University School of Medicine